title: [Usefulness of fentanyl patch (Durotep) in cancer patients when rotated from morphine preparations].
abstract: BACKGROUND
  [corrected] The transdermal fentanyl patch (Durote patch) is an opioid preparation requiring replacement once in three days, which is occasionally prescribed to replace morphine preparations. The conversion ratio from morphine to fentanyl has been claimed to be 100:1 or 150:1, but there may exist individual variations.
  
  
  METHODS
  We retrospectively evaluated the analgesic effects and adverse effects of fentanyl patch in 24 cases among 22 patients (11 men and 11 women).
  
  
  RESULTS
  There were some reasons for switching; the major one was for home-care. In most cases rotation was completed in a few days and the side effects disappearance or were reduced, but 4 cases of them showed severe diarrhea or exhibited exacerbation of the pain, and had to go back to morphine. There were a wide variations of conversion ratio with a mean of 96.6.
  
  
  CONCLUSIONS
  The fentanyl patch is a useful agent to control severe cancer pain because of excellent analgesic effect, less adverse effects and more convenience as well as itsundesirable characteristics when transition of patients to home-care is considered or oral administration should be avoided. Above all it offers a great possibility to improve cancer patient's quality of life.
authors: Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo.
authors: Yasuko
authors: Y
authors: Akiyama
authors: Masako
authors: M
authors: Iseki
authors: Rika
authors: R
authors: Izawa
authors: Kouta
authors: K
authors: Ishii
authors: Toyo
authors: T
authors: Miyazaki
authors: Seiko
authors: S
authors: Yamaguchi
authors: Yuichiro
authors: Y
authors: Tani
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage* / Q000009:adverse effects*; D009369:Neoplasms / Q000150:complications*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology*; D010166:Palliative Care; D011788:Quality of Life; D012189:Retrospective Studies
chemical_list: D000701:Analgesics, Opioid; D009020:Morphine; D005283:Fentanyl